Stability of body weight in type 2 diabetes

OBJECTIVE - There is a concern that an epidemic of obesity is occurring in societies. One consequence of obesity is that type 2 diabetes may develop. Presumably, a great increase in body weight would continue in people With diabetes and may be accelerated due pharmacological treatment. In this retrospective study, we tested the hypothesis that the gain in a diabetic population is greater than that in the general population. RESEARCH DESIGN AND METHODS - Data were obtained from the records of adult men who have attended a diabetes clinic for :5 years. Their weight and at the last visit were compared with the initial Visit data. The subjects were Categorized to treatment modalities. The mean follow-up was 9.4 years (range 5-23). RESULTS - For the group as a whole, the mean increase in body weight was 0.23 +/- 0.2 kg/year, BMI or initial age had little effect on the rate of weight gain. Treatment regimen used have an effect on weight change. In subjects treated with insulin, with or without oral body weight increased at a rate of 0.44 +/- 0.1 kg/year. In subjects treated With metformin metformin and a sulfonylurea, there was a mean loss in weight, i.e., -0.24 +/- 0.09 kg/year, with sulfonylureas alone weight increased by 0.42 +/- 0.2 kg/year. CONCLUSIONS - The men treated With insulin alone or insulin combined With oral gained weight at a rate comparable with that reported for the general population, i.e., the gain was not extraordinary. Metformin treatment resulted in a modest loss of weight.